Platelet-Derived Growth Factor CC-Mediated Neuroprotection against HIV Tat Involves TRPC-Mediated Inactivation of GSK 3beta

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Peng, Fuwang ^a   Yao, Honghong ^a   Akturk, Halis Kaan ^b   Buch, Shilpa ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Creighton Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; GLYCOGEN SYNTHASE KINASE 3BETA; MICROTUBULE ASSOCIATED PROTEIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR CC; PROTEIN KINASE B; TRANSACTIVATOR PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; NEURITE; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CALCIUM; CELL LINE, TUMOR; DEMENTIA; GLYCOGEN SYNTHASE KINASE 3; HIV INFECTIONS; HUMANS; LYMPHOKINES; MICROTUBULE-ASSOCIATED PROTEINS; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS;

EID: 84867512992     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047572     Document Type: Article

References (95)

1. Albright AV, Soldan SS, Gonzalez-Scarano F, (2003) Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol 9: 222-227.
2. McArthur JC, Brew BJ, Nath A, (2005) Neurological complications of HIV infection. Lancet Neurol 4: 543-555.
3. Navia BA, Jordan BD, Price RW, (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517-524.
4. Bell JE, (1998) The neuropathology of adult HIV infection. Rev Neurol (Paris) 154: 816-829.
5. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HS, (1994) The neuropathogenesis of HIV-1 infection. J Leukoc Biol 56: 389-398.
6. Nath A, (1999) Pathobiology of human immunodeficiency virus dementia. Semin Neurol 19: 113-127.
7. Zauli G, Secchiero P, Rodella L, Gibellini D, Mirandola P, et al. (2000) HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J Biol Chem 275: 4159-4165.
8. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW, (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 85: 1299-1311.
9. Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, et al. (2000) Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6: 1380-1387.
10. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, et al. (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70: 1475-1480.
11. Hudson L, Liu J, Nath A, Jones M, Raghavan R, et al. (2000) Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 6: 145-155.
12. Wiley CA, Baldwin M, Achim CL, (1996) Expression of HIV regulatory and structural mRNA in the central nervous system. Aids 10: 843-847.
13. Kumar A, Dhawan S, Mukhopadhyay A, Aggarwal BB, (1999) Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett 462: 140-144.
14. McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, et al. (2000) Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 156: 1441-1453.
15. Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, et al. (1999) Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65: 458-465.
16. Alzheimer C, Werner S, (2002) Fibroblast growth factors and neuroprotection. Adv Exp Med Biol 513: 335-351.
17. Deierborg T, Soulet D, Roybon L, Hall V, Brundin P, (2008) Emerging restorative treatments for Parkinson's disease. Prog Neurobiol 85: 407-432.
18. Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, et al. (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12: 1329-1343.
19. Colafrancesco V, Villoslada P, (2011) Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases. Arch Ital Biol 149: 183-192.
20. Pietz K, Odin P, Funa K, Lindvall O, (1996) Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture. Neurosci Lett 204: 101-104.
21. Heldin CH, Eriksson U, Ostman A, (2002) New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 398: 284-290.
22. Heldin CH, Westermark B, (1990) Signal transduction by the receptors for platelet-derived growth factor. J Cell Sci 96 (Pt 2): 193-196.
23. Ding H, Wu X, Bostrom H, Kim I, Wong N, et al. (2004) A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat Genet 36: 1111-1116.
24. Ding H, Wu X, Kim I, Tam PP, Koh GY, et al. (2000) The mouse Pdgfc gene: dynamic expression in embryonic tissues during organogenesis. Mech Dev 96: 209-213.
25. Egawa-Tsuzuki T, Ohno M, Tanaka N, Takeuchi Y, Uramoto H, et al. (2004) The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol 186: 89-98.
26. Subramaniam S, Shahani N, Strelau J, Laliberte C, Brandt R, et al. (2005) Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J Neurosci 25: 2838-2852.
27. Zheng WH, Quirion R, (2004) Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. J Neurochem 89: 844-852.
28. Liot G, Gabriel C, Cacquevel M, Ali C, MacKenzie ET, et al. (2004) Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis. Exp Neurol 187: 38-46.
29. Wu Y, Shang Y, Sun S, Liang H, Liu R, (2007) Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12: 1365-1375.
30. Wang L, Yang HJ, Xia YY, Feng ZW, (2010) Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3beta/JNK signaling. Apoptosis 15: 1470-1479.
31. Sossin WS, Barker PA, (2007) Something old, something new: BDNF-induced neuron survival requires TRPC channel function. Nat Neurosci 10: 537-538.
32. Jia Y, Zhou J, Tai Y, Wang Y, (2007) TRPC channels promote cerebellar granule neuron survival. Nat Neurosci 10: 559-567.
33. Everall IP, Bell C, Mallory M, Langford D, Adame A, et al. (2002) Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol Cell Neurosci 21: 493-501.
34. Sanders VJ, Everall IP, Johnson RW, Masliah E, (2000) Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells. HNRC Group. J Neurosci Res 59: 671-679.
35. Hollman AM, Christian DA, Ray PD, Galey D, Turchan J, et al. (2005) Selective isolation and purification of tat protein via affinity membrane separation. Biotechnol Prog 21: 451-459.
36. Ma M, Nath A, (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495-2499.
37. Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, et al. (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2: 3.
38. Tang Z, Arjunan P, Lee C, Li Y, Kumar A, et al. (2010) Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J Exp Med 207: 867-880.
39. Brewer GJ, Torricelli JR, Evege EK, Price PJ, (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35: 567-576.
40. Yao H, Kim K, Duan M, Hayashi T, Guo M, et al. (2011) Cocaine Hijacks {sigma}1 Receptor to Initiate Induction of Activated Leukocyte Cell Adhesion Molecule: Implication for Increased Monocyte Adhesion and Migration in the CNS. J Neurosci 31: 5942-5955.
41. Peng F, Dhillon N, Callen S, Yao H, Bokhari S, et al. (2008) Platelet-derived growth factor protects neurons against gp120-mediated toxicity. J Neurovirol 14: 62-72.
42. Lu M, Branstrom R, Berglund E, Hoog A, Bjorklund P, et al. (2010) Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid. J Mol Endocrinol 44: 285-294.
43. Constantino AA, Huang Y, Zhang H, Wood C, Zheng JC, (2011) HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity. Neurotox Res 20: 277-288.
44. Mattson MP, (2004) Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders. Ann N Y Acad Sci 1012: 37-50.
45. Iskander S, Walsh KA, Hammond RR, (2004) Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia. J Neuroinflammation 1: 7.
46. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, et al. (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42: 963-972.
47. Xu Y, Kulkosky J, Acheampong E, Nunnari G, Sullivan J, et al. (2004) HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc Natl Acad Sci U S A 101: 7070-7075.
48. Kruman, II, Nath A, Mattson MP, (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154: 276-288.
49. Singh IN, Goody RJ, Dean C, Ahmad NM, Lutz SE, et al. (2004) Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. J Neurovirol. 10: 141-151.
50. Tagami M, Ikeda K, Nara Y, Fujino H, Kubota A, et al. (1997) Insulin-like growth factor-1 attenuates apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Lab Invest 76: 613-617.
51. Cui W, Li W, Zhao Y, Mak S, Gao Y, et al. (2011) Preventing HO-induced apoptosis in cerebellar granule neurons by regulating the VEGFR-2/Akt signaling pathway using a novel dimeric antiacetylcholinesterase bis(12)-hupyridone. Brain Res 1394: 14-23.
52. Peng F, Yao H, Bai X, Zhu X, Reiner BC, et al. (2010) Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. J Biol Chem 285: 21615-21624.
53. McGary EC, Weber K, Mills L, Doucet M, Lewis V, et al. (2002) Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8: 3584-3591.
54. Leevers SJ, Vanhaesebroeck B, Waterfield MD, (1999) Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 11: 219-225.
55. Shaw RJ, Cantley LC, (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441: 424-430.
56. Courtney KD, Corcoran RB, Engelman JA, (2010) The PI3K pathway as drug target in human cancer. J Clin Oncol 28: 1075-1083.
57. Lim JY, Park SI, Oh JH, Kim SM, Jeong CH, et al. (2008) Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J Neurosci Res 86: 2168-2178.
58. Mizoguchi Y, Monji A, Kato T, Seki Y, Gotoh L, et al. (2009) Brain-derived neurotrophic factor induces sustained elevation of intracellular Ca2+ in rodent microglia. J Immunol 183: 7778-7786.
59. Kuribara M, Eijsink VD, Roubos EW, Jenks BG, Scheenen WJ, (2010) BDNF stimulates Ca2+ oscillation frequency in melanotrope cells of Xenopus laevis: contribution of IP3-receptor-mediated release of intracellular Ca2+ to gene expression. Gen Comp Endocrinol 169: 123-129.
60. Yue J, Wei W, Lam CM, Zhao YJ, Dong M, et al. (2009) CD38/cADPR/Ca2+ pathway promotes cell proliferation and delays nerve growth factor-induced differentiation in PC12 cells. J Biol Chem 284: 29335-29342.
61. Apati A, Janossy J, Brozik A, Bauer PI, Magocsi M, (2003) Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1. J Biol Chem 278: 9235-9243.
62. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, et al. (1990) SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271: 515-522.
63. Zhu X, Jiang M, Birnbaumer L, (1998) Receptor-activated Ca2+ influx via human Trp3 stably expressed in human embryonic kidney (HEK)293 cells. Evidence for a non-capacitative Ca2+ entry. J Biol Chem 273: 133-142.
64. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
65. L'Episcopo F, Serapide MF, Tirolo C, Testa N, Caniglia S, et al. (2011) A Wnt1 regulated Frizzled-1/beta-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection. Mol Neurodegener 6: 49.
66. Li HL, Wang HH, Liu SJ, Deng YQ, Zhang YJ, et al. (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc Natl Acad Sci U S A 104: 3591-3596.
67. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, et al. (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9: 205-221.
68. Everall IP, Luthert PJ, Lantos PL, (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119-1121.
69. Adamson DC, Dawson TM, Zink MC, Clements JE, Dawson VL, (1996) Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med 2: 417-428.
70. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, et al. (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
71. Chen Z, Huang Y, Zhao X, Skulsky E, Lin D, et al. (2000) Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). J Virol 74: 6501-6510.
72. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA, (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364-367.
73. Hof PR, Lee PY, Yeung G, Wang RF, Podos SM, et al. (1998) Glutamate receptor subunit GluR2 and NMDAR1 immunoreactivity in the retina of macaque monkeys with experimental glaucoma does not identify vulnerable neurons. Exp Neurol 153: 234-241.
74. Kruman I, Guo Q, Mattson MP, (1998) Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res 51: 293-308.
75. Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M,et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 207: 807-821.
76. Bachis A, Mocchetti I, (2005) Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins. Ann N Y Acad Sci 1053: 247-257.
77. Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, et al. (2002) Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection. J Biol Chem 277: 32985-32991.
78. Wang L, Gang Zhang Z, Lan Zhang R, Chopp M, (2005) Activation of the PI3-K/Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone. J Cereb Blood Flow Metab 25: 1150-1158.
79. Zhang SX, Gozal D, Sachleben LR Jr, Rane M, Klein JB, et al. (2003) Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells. Faseb J 17: 1709-1711.
80. Kucharzewska P, Welch JE, Svensson KJ, Belting M, (2009) The polyamines regulate endothelial cell survival during hypoxic stress through PI3K/AKT and MCL-1. Biochem Biophys Res Commun 380: 413-418.
81. Chung WH, Pak K, Lin B, Webster N, Ryan AF, (2006) A PI3K pathway mediates hair cell survival and opposes gentamicin toxicity in neonatal rat organ of Corti. J Assoc Res Otolaryngol 7: 373-382.
82. Manning BD, Cantley LC, (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
83. Brini M, Carafoli E, (2009) Calcium pumps in health and disease. Physiol Rev 89: 1341-1378.
84. De Smedt H, Verkhratsky A, Muallem S, (2011) Ca(2+) signaling mechanisms of cell survival and cell death: an introduction. Cell Calcium 50: 207-210.
85. Ariano P, Dalmazzo S, Owsianik G, Nilius B, Lovisolo D, (2011) TRPC channels are involved in calcium-dependent migration and proliferation in immortalized GnRH neurons. Cell Calcium 49: 387-394.
86. Clapham DE, Runnels LW, Strubing C, (2001) The TRP ion channel family. Nat Rev Neurosci 2: 387-396.
87. Facci L, Stevens DA, Skaper SD, (2003) Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity. Neuroreport 14: 1467-1470.
88. Doble BW, Woodgett JR, (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186.
89. Grimes CA, Jope RS, (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426.
90. Gordon MD, Nusse R, (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281: 22429-22433.
91. Salins P, Shawesh S, He Y, Dibrov A, Kashour T, et al. (2007) Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling. Neurosci Lett 412: 211-216.
92. Pei Y, Brun SN, Markant SL, Lento W, Gibson P,et al. WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum. Development 139: 1724-1733.
93. Korade Z, Mirnics K, (2011) Wnt signaling as a potential therapeutic target for frontotemporal dementia. Neuron 71: 955-957.
94. Souaze F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, et al. (2006) Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. Carcinogenesis 27: 708-716.
95. Arrazola MS, Varela-Nallar L, Colombres M, Toledo EM, Cruzat F, et al. (2009) Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. J Cell Physiol 221: 658-667.